Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27491805 | 1.00 | HDAC1 (0.51) | HDAC1HDAC8HDAC6KMT2APOLB | |
| SCHEMBL5369178 | 0.91 | L3MBTL1 (0.49) | HDAC1HDAC8HDAC6KMT2APOLB | |
| SCHEMBL9740346 | 0.89 | L3MBTL1 (0.51) | HDAC1HDAC8HDAC6KMT2APOLB | |
| SCHEMBL9205385 | 0.88 | L3MBTL1 (0.54) | HDAC1HDAC8HDAC6KMT2APOLB | |
| SCHEMBL7779965 | 0.88 | HDAC1 (0.49) | HDAC1HDAC8HDAC6KMT2APOLB | |
| SCHEMBL13326692 | 0.88 | HDAC1 (0.52) | HDAC1HDAC8HDAC6KMT2APOLB | |
| SCHEMBL7829097 | 0.88 | HDAC1 (0.49) | HDAC1HDAC8HDAC6KMT2APOLB | |
| SCHEMBL5980733 | 0.85 | HDAC1 (0.47) | HDAC1HDAC8HDAC6KMT2APOLB | |
| SCHEMBL5979605 | 0.85 | HDAC1 (0.47) | HDAC1HDAC8HDAC6KMT2APOLB | |
| SCHEMBL28116823 | 0.84 | CCR8 (0.53) | KMT2APOLBGAAALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022095-A1 | COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF | ADAMA AGAN LTD. (IL) | 2026-01-22 | — | — | US | disclosed |
| US-20250197350-A1 | COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF | ADAMA AGAN LTD. (IL) | 2025-06-19 | — | — | US | disclosed |
| US-20250066297-A1 | COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF | ADAMA AGAN LTD. (IL) | 2025-02-27 | — | — | US | disclosed |
| EP-4508980-A2 | COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF | Adama Agan Ltd. (IL) | 2025-02-19 | — | — | EP | disclosed |
| EP-4483714-A2 | COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF | Adama Agan Ltd. (IL) | 2025-01-01 | — | — | EP | disclosed |
| EP-4447681-A2 | COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF | Adama Agan Ltd. (IL) | 2024-10-23 | — | — | EP | disclosed |
| CN-118401112-A | Compounds for preparing various agrochemicals and markers thereof | 安道麦阿甘有限公司 | 2024-07-26 | — | — | CN | disclosed |
| EP-4063358-B1 | HISTONE METHYLTRANSFERASE INHIBITORS | GLOBAL BLOOD THERAPEUTICS INC (US) | 2024-05-22 | — | — | EP | disclosed |
| US-11713299-B2 | Histone methyltransferase inhibitors | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2023-08-01 | — | — | US | disclosed |
| WO-2023112033-A2 | COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF | ADAMA AGAN LTD. (IL) | 2023-06-22 | — | — | WO | disclosed |
| EP-1395585-B1 | ANTIBACTERIAL AGENTS | WARNER LAMBERT CO (US) | 2006-01-04 | — | — | EP | disclosed |
| US-6864259-B2 | Antibacterial agents | WARNER-LAMBERT COMPANY (US) | 2005-03-08 | — | — | US | disclosed |
| EP-1401830-A2 | QUINAZOLINEDIONES AS ANTIBACTERIAL AGENTS | Warner-Lambert Company LLC (US) | 2004-03-31 | — | — | EP | disclosed |
| US-20030114666-A1 | Having quinazolindione core structure; non-antibiotic resistance | WARNER-LAMBERT COMPANY | 2003-06-19 | — | — | US | disclosed |
| US-20030114458-A1 | Antibacterial agents | WARNER-LAMBERT COMPANY | 2003-06-19 | — | — | US | disclosed |
| WO-2002102793-A2 | QUINAZOLINEDIONES AS ANTIBACTERIAL AGENTS | WARNER-LAMBERT COMPANY LLC (US) | 2002-12-27 | — | — | WO | disclosed |
| EP-0341493-B1 | Optically active pyridonecarboxylic acid derivatives | DAIICHI SEIYAKU CO (JP) | 1999-07-14 | — | — | EP | disclosed |
| CN-1033751-C | Optically active pyridonecarboxylic acid derivatives | DAIICHI SEIYAKU CO (JP) | 1997-01-08 | — | — | CN | disclosed |
| US-5175157-A | Cardiovascular disorders | BOEHRINGER INGELHEIM GMBH (DE) | 1992-12-29 | — | — | US | disclosed |
| EP-0341493-A2 | Optically active pyridonecarboxylic acid derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1989-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030114666-A1 | Having quinazolindione core structure; non-antibiotic resistance | ABCC1, RPS6KA1, SIGMAR1 | HDAC1 666/4885HDAC8 2036/4885HDAC6 1768/4885 |
| US-20260022095-A1 | COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF | TET1, FOXK1, TET3 | HDAC1 1226/4885HDAC8 3192/4885HDAC6 3441/4885 |
| US-20030114458-A1 | Antibacterial agents | MRPL21, RPS6, RPS6KA1 | HDAC1 679/4885HDAC8 2138/4885HDAC6 1519/4885 |
| US-20250197350-A1 | COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF | GYS2, PFAS, CD68 | HDAC1 1513/4885HDAC8 1746/4885HDAC6 1574/4885 |
| US-20250066297-A1 | COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF | GYS2, PFAS, CD68 | HDAC1 1513/4885HDAC8 1746/4885HDAC6 1574/4885 |
| US-11713299-B2 | Histone methyltransferase inhibitors | EHMT1, DOT1L, EHMT2 | HDAC1 96/4885HDAC8 179/4885HDAC6 471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.